215 related articles for article (PubMed ID: 24987904)
41. Exocrine pancreatic insufficiency in distal pancreatectomy: incidence and risk factors.
Hallac A; Aleassa EM; Rogers M; Falk GA; Morris-Stiff G
HPB (Oxford); 2020 Feb; 22(2):275-281. PubMed ID: 31327560
[TBL] [Abstract][Full Text] [Related]
42. Risk factors for mortality and intra-abdominal morbidity after distal pancreatectomy.
Sledzianowski JF; Duffas JP; Muscari F; Suc B; Fourtanier F
Surgery; 2005 Feb; 137(2):180-5. PubMed ID: 15674199
[TBL] [Abstract][Full Text] [Related]
43. Impact of diabetes mellitus on perioperative outcomes after resection for pancreatic adenocarcinoma.
Chu CK; Mazo AE; Sarmiento JM; Staley CA; Adsay NV; Umpierrez GE; Kooby DA
J Am Coll Surg; 2010 Apr; 210(4):463-73. PubMed ID: 20347739
[TBL] [Abstract][Full Text] [Related]
44. Clinical Characteristics and Risk Factors for the Development of Postoperative Hepatic Steatosis After Total Pancreatectomy.
Hata T; Ishida M; Motoi F; Sakata N; Yoshimatsu G; Naitoh T; Katayose Y; Egawa S; Unno M
Pancreas; 2016 Mar; 45(3):362-9. PubMed ID: 26495776
[TBL] [Abstract][Full Text] [Related]
45. A prospectively validated clinical risk score accurately predicts pancreatic fistula after pancreatoduodenectomy.
Callery MP; Pratt WB; Kent TS; Chaikof EL; Vollmer CM
J Am Coll Surg; 2013 Jan; 216(1):1-14. PubMed ID: 23122535
[TBL] [Abstract][Full Text] [Related]
46. Personal experience with the Whipple operation: outcomes and lessons learned.
Hoshal VL; Benedict MB; David LR; Kulick J
Am Surg; 2004 Feb; 70(2):121-5; discussion 126. PubMed ID: 15011913
[TBL] [Abstract][Full Text] [Related]
47. Risk factors for complications after pancreatic head resection.
Adam U; Makowiec F; Riediger H; Schareck WD; Benz S; Hopt UT
Am J Surg; 2004 Feb; 187(2):201-8. PubMed ID: 14769305
[TBL] [Abstract][Full Text] [Related]
48. A novel postoperative inflammatory score predicts postoperative pancreatic fistula after pancreatic resection.
Fujiwara Y; Misawa T; Shiba H; Shirai Y; Iwase R; Haruki K; Furukawa K; Futagawa Y; Yanaga K
Anticancer Res; 2013 Nov; 33(11):5005-10. PubMed ID: 24222143
[TBL] [Abstract][Full Text] [Related]
49. Malnutrition and pancreatic surgery: prevalence and outcomes.
La Torre M; Ziparo V; Nigri G; Cavallini M; Balducci G; Ramacciato G
J Surg Oncol; 2013 Jun; 107(7):702-8. PubMed ID: 23280557
[TBL] [Abstract][Full Text] [Related]
50. Nontherapeutic celiotomy incidence is not affected by volume of pancreaticoduodenectomy for pancreatic adenocarcinoma.
Toomey P; Childs C; Luberice K; Ross S; Rosemurgy A
Am Surg; 2013 Aug; 79(8):781-5. PubMed ID: 23896244
[TBL] [Abstract][Full Text] [Related]
51. Postoperative pancreatic fistula following distal pancreatectomy for pancreatic neoplasm; can pancreatic fistula be prevented?
Okabayashi T; Kobayashi M; Sugimoto T; Namikawa T; Okamoto K; Hokimoto N; Araki K
Hepatogastroenterology; 2004; 51(60):1838-41. PubMed ID: 15532838
[TBL] [Abstract][Full Text] [Related]
52. Pancreatic head resection with segmental duodenectomy: safety and long-term results.
Nakao A; Fernández-Cruz L
Ann Surg; 2007 Dec; 246(6):923-8; discussion 929-31. PubMed ID: 18043093
[TBL] [Abstract][Full Text] [Related]
53. Preoperative serum C-reactive protein levels and post-operative lymph node ratio are important predictors of survival after pancreaticoduodenectomy for pancreatic ductal adenocarcinoma.
Sanjay P; de Figueiredo RS; Leaver H; Ogston S; Kulli C; Polignano FM; Tait IS
JOP; 2012 Mar; 13(2):199-204. PubMed ID: 22406601
[TBL] [Abstract][Full Text] [Related]
54. Impact of pancreatic cancer and subsequent resection on glycemic control in diabetic and nondiabetic patients.
White MA; Agle SC; Fuhr HM; Mehaffey JH; Waibel BH; Zervos EE
Am Surg; 2011 Aug; 77(8):1032-7. PubMed ID: 21944519
[TBL] [Abstract][Full Text] [Related]
55. Impact of preoperative asymptomatic renal dysfunction on clinical course after pancreatoduodenectomy.
Nagai M; Sho M; Akahori T; Tanaka T; Kinoshita S; Nishiofuku H; Nishiwada S; Ohbayashi C; Kichikawa K; Nakajima Y
J Hepatobiliary Pancreat Sci; 2015 Nov; 22(11):810-8. PubMed ID: 26333519
[TBL] [Abstract][Full Text] [Related]
56. Middle pancreatectomy: safety and long-term results.
Shikano T; Nakao A; Kodera Y; Yamada S; Fujii T; Sugimoto H; Kanazumi N; Nomoto S; Takeda S
Surgery; 2010 Jan; 147(1):21-9. PubMed ID: 19682717
[TBL] [Abstract][Full Text] [Related]
57. Curative resection is the single most important factor determining outcome in patients with pancreatic adenocarcinoma.
Wagner M; Redaelli C; Lietz M; Seiler CA; Friess H; Büchler MW
Br J Surg; 2004 May; 91(5):586-94. PubMed ID: 15122610
[TBL] [Abstract][Full Text] [Related]
58. Examining the accuracy and clinical usefulness of intraoperative frozen section analysis in the management of pancreatic lesions.
Nelson DW; Blanchard TH; Causey MW; Homann JF; Brown TA
Am J Surg; 2013 May; 205(5):613-7; discussion 617. PubMed ID: 23592172
[TBL] [Abstract][Full Text] [Related]
59. Lymph node involvement beyond peripancreatic region in pancreatic head cancers: when results belie expectations.
Golse N; Lebeau R; Lombard-Bohas C; Hervieu V; Ponchon T; Adham M
Pancreas; 2013 Mar; 42(2):239-48. PubMed ID: 23038054
[TBL] [Abstract][Full Text] [Related]
60. Surgical treatment of pancreatic head carcinoma in elderly patients.
Brozzetti S; Mazzoni G; Miccini M; Puma F; De Angelis M; Cassini D; Bettelli E; Tocchi A; Cavallaro A
Arch Surg; 2006 Feb; 141(2):137-42. PubMed ID: 16490889
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
